Related Experiment Videos
Unstable angina. Pharmaceutical versus invasive therapy
L M Prisant1, J L Houghton, P B Bottini
1Sections of Cardiology and of Hypertension and Vascular Diseases, Medical College of Georgia, Augusta.
Postgraduate Medicine
|July 1, 1994
Summary
Patients with persistent chest pain unresponsive to nitroglycerin require intensive care and prompt pharmacologic therapy. Refractory symptoms warrant coronary arteriography and potential invasive procedures like angioplasty or bypass grafting for unstable angina management.
Area of Science:
- Cardiology
- Emergency Medicine
- Clinical Pharmacology
Background:
- Unstable angina is a critical precursor to myocardial infarction and death.
- Prompt recognition and management of refractory chest pain are vital.
Purpose of the Study:
- To outline the recommended management pathway for patients presenting with chest pain refractory to initial treatment.
- To define criteria for escalation of care and intervention in unstable angina.
Main Methods:
- Review of clinical guidelines and evidence for managing unstable angina.
- Description of diagnostic and therapeutic interventions based on symptom persistence and patient risk.
Main Results:
- Hospitalization in an intensive care unit is recommended for persistent chest pain (>20 minutes) unresponsive to sublingual nitroglycerin.
- Pharmacologic therapy should be initiated promptly.
- Coronary arteriography is indicated for persistent symptoms despite medical management.
- Invasive procedures (angioplasty, coronary artery bypass grafting) should be considered for high-risk patients.
- Delaying invasive procedures until stabilization is appropriate when necessary.
Conclusions:
- A structured approach involving intensive care, pharmacologic therapy, and selective invasive procedures is crucial for managing unstable angina.
- Timely intervention based on symptom response and risk stratification improves patient outcomes and reduces mortality risk.